MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 5 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding MoonLake Immunotherapeutics changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 24 | 1 | 33 | +10 |
| Shares | 36.9M | 67.7K | 37.7M | +960.7K (+2.6%) |
| Value | $291.4M | $525.0K | $396.4M | +$105.5M (+36.3%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held MoonLake Immunotherapeutics at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Polar Capital Holdings Plc | 876,377 | $9.20M | 0.07% |
| AXA S.A. | 405,284 | $4.26M | 0.02% |
| Braidwell LP | 381,120 | $4.00M | 0.13% |
| Acuta Capital Partners, LLC | 93,500 | $981.8K | 0.60% |
| Jefferies Financial Group Inc. | 67,654 | $710.4K | 0.01% |
| JPMorgan Chase & Co | 44,844 | $471.0K | 0.00% |
| Cheyne Capital Management (UK) LLP | 32,129 | $337.4K | 0.60% |
| SVB Financial Group | 16,173 | $169.8K | 0.46% |
| Virtu Financial LLC | 14,395 | $151.0K | 0.02% |
| Two Sigma Investments, LP | 12,385 | $130.0K | 0.00% |
| Renaissance Technologies LLC | 11,609 | $122.0K | 0.00% |
| Geode Capital Management, LLC | 11,451 | $120.0K | 0.00% |
| Bank of America Corp | 7,900 | $83.0K | 0.00% |
| Royal Bank of Canada | 76 | $1.00K | 0.00% |
Sold out (4)
Institutions that held MoonLake Immunotherapeutics at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 335,000 | $2.60M |
| Ghost Tree Capital, LLC | 300,000 | $2.33M |
| Monashee Investment Management LLC | 191,945 | $1.49M |
| Alps Advisors Inc | 20,144 | $160.0K |
Not filed for Q4 2022 yet (1)
Institutions that held MoonLake Immunotherapeutics at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jefferies Group LLC | 67,654 | $525.0K |